Men with nonseminomatous germ cell tumors (NSGCT) of the testicle without evidence of residual disease after radical orchiectomy (Clinical stage I; CS-I) are increasingly managed with active surveillance.
Men with nonseminomatous germ cell tumors (NSGCT) of the testicle without evidence of residual disease after radical orchiectomy (Clinical stage I; CS-I) are increasingly managed with active surveillance.